» Articles » PMID: 2152823

The Malignant Histiocytosis Sarcoma Virus, a Recombinant of Harvey Murine Sarcoma Virus and Friend Mink Cell Focus-forming Virus, Has Acquired Myeloid Transformation Specificity by Alterations in the Long Terminal Repeat

Overview
Journal J Virol
Date 1990 Jan 1
PMID 2152823
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The malignant histiocytosis sarcoma virus (MHSV), in contrast to other viruses with the ras oncogene, induces acute histiocytosis in newborn and adult mice. Molecular structure and function studies were initiated to determine the basis of its unique macrophage-transforming potential. Characterization of the genomic structure showed that the virus evolved by recombination of the Harvey murine sarcoma virus (Ha-MuSV) and a virus of the Friend-mink cell focus-forming virus family. Structural analysis of MHSV showed two regions of the genome that are basically different from the Ha-MuSV: (i) the ras gene, which is altered by a point mutation in codon 181 leading to a Cys----Ser substitution of the p21 protein, and (ii) the U3 region of the long terminal repeat, which is largely derived from F-MCFV and contains a deletion of one direct repeat as well as a duplication of an altered enhancer-like region. Biological studies of Ha-MuSV, MHSV, and recombinants between the two viruses show that the U3 region of the MHSV long terminal repeat is essential for the malignancy and specificity of the disease. A contributing role of the ras point mutation in determining macrophage specificity, however, cannot be excluded.

Citing Articles

The potent enhancer activity of the polycythemic strain of spleen focus-forming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for....

Baum C, Itoh K, Meyer J, Laker C, Ito Y, Ostertag W J Virol. 1997; 71(9):6323-31.

PMID: 9261349 PMC: 191905. DOI: 10.1128/JVI.71.9.6323-6331.1997.


Anoxia-inducible rat VL30 elements and their relationship to ras-containing sarcoma viruses.

Firulli B, Anderson G, Stoler D, Estes S J Virol. 1993; 67(11):6857-62.

PMID: 8411389 PMC: 238132. DOI: 10.1128/JVI.67.11.6857-6862.1993.


Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.

Baum C, Hegewisch-Becker S, ECKERT H, Stocking C, Ostertag W J Virol. 1995; 69(12):7541-7.

PMID: 7494260 PMC: 189692. DOI: 10.1128/JVI.69.12.7541-7547.1995.

References
1.
Velu T, Vass W, Lowy D, Tambourin P . Harvey murine sarcoma virus: influences of coding and noncoding sequences on cell transformation in vitro and oncogenicity in vivo. J Virol. 1989; 63(3):1384-92. PMC: 247837. DOI: 10.1128/JVI.63.3.1384-1392.1989. View

2.
Lacal J, Anderson P, Aaronson S . Deletion mutants of Harvey ras p21 protein reveal the absolute requirement of at least two distant regions for GTP-binding and transforming activities. EMBO J. 1986; 5(4):679-87. PMC: 1166844. DOI: 10.1002/j.1460-2075.1986.tb04267.x. View

3.
Dube S, Kung H, Bender W, Davidson N, Ostertag W . Size, subunit composition, and secondary structure of the Friend virus genome. J Virol. 1976; 20(1):264-72. PMC: 354987. DOI: 10.1128/JVI.20.1.264-272.1976. View

4.
Pragnell I, Ostertag W, Paul J . The expression of viral and globin genes during differentiation of the Friend cell. Exp Cell Res. 1977; 108(2):269-78. DOI: 10.1016/s0014-4827(77)80034-7. View

5.
SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View